References
-
1
Doherty D C, Ortel T L, de Bruijn N, Greenberg C S, van Trigt P.
“Heparin-free” cardiopulmonary bypass. First reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass.
Anesthesiology.
1990;
73
562-565
-
2
Prifti E, Bonacchi M, Leacche M, Miraldi F.
Undergoing cardiopulmonary bypass using enoxaparin only during a cardiac transplantation procedure.
Eur J Cardiothorac Surg.
2000;
17
760-762
-
3
Christiansen S, Jahn U R, Meyer J, Scheld H H, Van Aken H, Kehrel B E, Hammel D.
Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
Ann Thorac Surg.
2000;
69
774-777
-
4
Christiansen S, Hammel D, Schmidt C, Scheld H H.
Heparin in patients with heparin-induced thrombocytopenia type II requiring LVAD implantation and cardiac transplantation.
J Heart Lung Transplant.
2000;
19
510-512
-
5
Potzsch B, Klovekorn W P, Madlener K.
Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia.
N Engl J Med.
2000;
343
515
Dr. med. S. Christiansen
Klinik und Poliklinik für Thorax-, Herz- und Gefäßchirurgie
Westfälische Wilhelms-Universität Münster
Albert-Schweitzer-Straße 33
48149 Münster
Phone: + 49-251-8347401
Fax: + 49-251-8348316
Email: stefan.christiansen@thgms.uni-muenster.de